Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 10842224)

Published in J Comp Neurol on June 26, 2000

Authors

M Egertová1, M R Elphick

Author Affiliations

1: School of Biological Sciences, Queen Mary and Westfield College, University of London, London E1 4NS, United Kingdom.

Articles citing this

The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12

Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci (2006) 2.81

Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci (2009) 1.88

Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 1.37

Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. Physiol Behav (2007) 1.22

Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (2004) 1.19

Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology (2007) 1.15

Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res (2010) 1.13

Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience (2010) 1.10

Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res (2006) 1.10

Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur J Neurosci (2009) 1.09

Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience (2007) 1.09

Endocannabinoids in the retina: from marijuana to neuroprotection. Prog Retin Eye Res (2008) 1.08

Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br J Pharmacol (2007) 1.07

Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm (Vienna) (2007) 1.05

Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci (2015) 1.04

Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. Psychopharmacology (Berl) (2007) 1.04

Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One (2012) 1.02

Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci (2016) 1.01

Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors. J Pharmacol Exp Ther (2009) 0.98

The evolution and comparative neurobiology of endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci (2012) 0.98

Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology (2010) 0.97

Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology (2009) 0.95

Dynamic regulation of the endocannabinoid system: implications for analgesia. Mol Pain (2009) 0.93

Cannabinoid modulation of cortical adrenergic receptors and transporters. J Neurosci Res (2009) 0.90

Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Mol Pain (2009) 0.90

Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex. Neurosci Lett (2007) 0.89

The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. Br J Pharmacol (2008) 0.89

Cannabinoid action in the olfactory epithelium. Proc Natl Acad Sci U S A (2007) 0.89

Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT. Psychopharmacology (Berl) (2008) 0.88

Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology (2011) 0.87

Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience (2011) 0.87

Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. Neuroscience (2010) 0.87

CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation. Front Pharmacol (2012) 0.86

Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia. Front Pharmacol (2012) 0.85

The effect of chronic cannabinoids on broadband EEG neural oscillations in humans. Neuropsychopharmacology (2012) 0.85

Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. Neuropsychopharmacology (2013) 0.84

Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. Hippocampus (2014) 0.83

A potential function of endocannabinoids in the selection of a navigation strategy by rats. Psychopharmacology (Berl) (2007) 0.83

CB₂: therapeutic target-in-waiting. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.83

Endocannabinoid signaling in neurotoxicity and neuroprotection. Neurotoxicology (2009) 0.82

Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans. Psychopharmacology (Berl) (2011) 0.82

Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054. Pharmacol Biochem Behav (2013) 0.81

Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. Brain Struct Funct (2014) 0.81

Extinction learning of rewards in the rat: is there a role for CB1 receptors? Psychopharmacology (Berl) (2011) 0.80

Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons. Brain Struct Funct (2012) 0.80

Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neurons. Exp Neurol (2011) 0.80

Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus. Front Neuroanat (2014) 0.79

Endocannabinoids in the dentate gyrus. Prog Brain Res (2007) 0.79

Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells. Brain Res (2010) 0.79

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans. PLoS One (2013) 0.78

Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. Brain Res Bull (2010) 0.78

Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat. Int J Biomed Sci (2008) 0.78

Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making. Psychopharmacology (Berl) (2014) 0.78

Endogenous modulators of synaptic transmission: cannabinoid regulation in the supraoptic nucleus. Prog Brain Res (2008) 0.78

Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice. PLoS One (2012) 0.78

Localization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus). Brain Res (2008) 0.77

Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? Neurotherapeutics (2015) 0.77

Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users. Neuropsychopharmacology (2014) 0.76

Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies. Front Neurol (2014) 0.76

Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis. J Psychopharmacol (2014) 0.76

Cannabinoid modulation of backpropagating action potential-induced calcium transients in layer 2/3 pyramidal neurons. Cereb Cortex (2012) 0.76

The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signalling. J Physiol (2013) 0.76

An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. Neuroscience (2015) 0.76

Developmental but not adult cannabinoid treatments persistently alter axonal and dendritic morphology within brain regions important for zebra finch vocal learning. Brain Res (2014) 0.75

Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. Lipids Health Dis (2017) 0.75

Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo. Springerplus (2015) 0.75

Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system. PLoS One (2017) 0.75

The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis. Psychoneuroendocrinology (2017) 0.75

Articles by these authors

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31

A genomic view of the sea urchin nervous system. Dev Biol (2006) 1.68

Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci (2000) 1.55

Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience (2003) 1.54

A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci (1998) 1.48

Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience (2003) 1.27

Tissue distribution of the SALMFamide neuropeptides S1 and S2 in the starfish Asterias rubens using novel monoclonal and polyclonal antibodies. I. Nervous and locomotory systems. Proc Biol Sci (1995) 0.96

Fatty acid amide hydrolase expression in rat choroid plexus: possible role in regulation of the sleep-inducing action of oleamide. Neurosci Lett (2000) 0.84

Effects of cytokines and nitric oxide donors on insulin secretion, cyclic GMP and DNA damage: relation to nitric oxide production. Biochem Soc Trans (1994) 0.77

Sensory afferents and motor neurons as targets for nitric oxide in the locust. J Comp Neurol (2000) 0.75

Nitric Oxide Function in an Echinoderm. Biol Bull (1998) 0.75